Picard Medical

PMI
  • Weekly Recap | Picard Medical -4.69%, a sharp rise-and-fall week

    Weekly Review·
    - Picard Medical (PMI.US) accumulated a drop of 4.69 % this week to close at $5.08, showing a volatile trend with a weekly amplitude of 39.75 %. - The stock movement was driven by short-term funds without fundamental catalysts, as institutional coverage remains minimal with a neutral consensus rating. - Future performance will depend on volume normalization and upcoming dense macroeconomic data releases.
  • Weekly Recap | Picard Medical -48.18%, violent swings after reverse split

    Weekly Review·
    - Picard Medical closed at 4.56 USD this week, marking a cumulative decline of 48.18 % amid severe volatility following a reverse stock split. - The company faces weak valuation and earnings support, with only 1 institutional coverage holding a neutral rating and a target price of 0 USD. - Market focus shifts to macroeconomic data releases and potential operational updates, as the stock lacks fundamental catalysts.
  • Weekly Recap | Picard Medical +174.14%, earnings beat estimates

    Weekly Review·
    - Picard Medical accumulated a 174.14% increase this week, closing at 8.8 dollars with a weekly amplitude of 158.17%. - The dramatic price and volume fluctuations were driven by better-than-expected second-quarter financial reports and the implementation of a reverse stock split. - The company is currently covered by only 1 institution with a neutral rating, while upcoming dense US macroeconomic data may create a transmission effect on the healthcare sector.